AK

Ajay Kumar

Active Director Director DIN 09273090
DIN 09273090 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Ajay Kumar

Data last updated:

Ajay Kumar is a Director at Izec Life Sciences Private Limited (since 2021). The company operates in Pharma. Izec Life Sciences Private Limited reported revenue of ₹24.7 Lakh (FY 2025).

DIN 09273090
Primary Designation Director
Industry Pharma
First Appointment 06 Aug 2021
Oldest Company Age 5 yrs
Largest company Izec Life Sciences Private Limited · ₹24.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Izec Life Sciences Private Limited U24110BR2021PTC053403
Director06 Aug 20212021₹24.7 Lakh (FY 2025)Active

Board colleagues of Ajay Kumar

Directorship timeline

Open interactive timeline →
Izec Life Sciences Private Limited
Premium access

Shareholding and investment profile for Ajay Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Kumar

Ajay Kumar currently holds 1 directorship: Izec Life Sciences Private Limited (Director, since 06 Aug 2021, revenue ₹24.7 Lakh (FY 2025)).

Ajay Kumar was first appointed on 06 Aug 2021 as Director at Izec Life Sciences Private Limited.

The current boards of Ajay Kumar's companies include Abhijeet Kumar (Izec Life Sciences Private Limited), Drawesh Kumar Jha (Izec Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available